Please ensure Javascript is enabled for purposes of website accessibility

Why Shares of Covetrus Tumbled Today

By Timothy Green - Updated Oct 22, 2019 at 12:25PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The animal health company made some abrupt management changes.

What happened

Shares of Covetrus (CVET 0.05%), a supplier of products, services, and software to the veterinary industry, were down on Tuesday after the company announced the resignation of its CEO. The stock had dropped 10.9% by 12:20 p.m. EDT.

So what

Benjamin Shaw has stepped down as president and CEO. Shaw had been at the helm since the company was formed by the merger of Vets First Choice and the animal health business of Henry Schein that was spun off earlier this year.

A declining chart.

Image source: Getty Images.

The stock has been slumping since soon after its debut, and now trades for around $9 per share, down from a 52-week high of nearly $44. No reason was given for the CEO's sudden departure.

Taking over as acting president and CEO is Benjamin Wolin, the current chairman of the board. Shaw will become a strategic adviser to the board, and independent director Philip Laskawy will become the new board chairman.

Now what

"We are taking action to focus and execute on a strategy that will propel this exciting and innovative company into the next phase of its evolution, while providing long-term value to our employees, shareholders, customers, and partners," Wolin said in the press release announcing the news.

Covetrus' recent results have been subpar, helping to fuel the stock's decline. Organic sales were down 1% in the second quarter, and adjusted net income tumbled 28% year over year. Both revenue and earnings badly missed analyst expectations.

While new leadership is likely a positive development, given the company's performance, investors punished the stock on Tuesday for the surprise development.

Timothy Green has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Covetrus, Inc. Stock Quote
Covetrus, Inc.
CVET
$20.83 (0.05%) $0.01

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
397%
 
S&P 500 Returns
128%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/19/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.